Abstract-This study was designed to examine whether L-arginine could prevent hypertension-and age-related impairment of coronary hemodynamics and cardiac fibrosis in aged (80-week-old) rats. To differentiate between hypertension-and age-related changes, the study was performed in both normotensive Wistar-Kyoto rats (WKYs) and spontaneously hypertensive rats (SHR). Male 1-year-old rats of both strains were divided into 2 groups and given either placebo or L-arginine (1.2 g/L) in drinking water. After 6 months, systemic and coronary hemodynamics (radionuclide-labeled microspheres), right and left ventricular and aortic mass indexes, and ventricular hydroxyproline (an estimate of collagen) concentrations were determined. In the aged WKYs, L-arginine did not affect any of the examined variables except slightly reducing total peripheral resistance. In contrast, L-arginine diminished arterial pressure, total peripheral resistance, and left ventricular and aortic mass indexes in the SHRs; it also increased coronary flow reserve and reduced minimal coronary flow resistance and myocardial hydroxyproline concentration. Key Words: hypertension Ⅲ aging Ⅲ mass, ventricular Ⅲ mass, aortic Ⅲ hemodynamics, coronary Ⅲ myocardial collagen concentration Ⅲ L-arginine M orphological and functional changes that occur in the cardiovascular system with hypertension and aging are similar in many respects. 1-4 They include impaired cardiac performance and coronary hemodynamics and ventricular fibrosis. [5][6][7][8][9] In a recent study involving normotensive and spontaneously hypertensive rats (SHRs), aged 22, 35 and 65 weeks, we demonstrated that associated with aging per se there were progressive impairments in coronary hemodynamics with increased myocardial collagen deposition in both strains. 9 These changes were more pronounced in hypertensive rats at any age, as if hypertension might have induced premature aging alterations of cardiovascular system.Much evidence exists that suggests that the endothelium, in autocrine/paracrine and endocrine manners, participates in regulating cardiovascular structure and function. 10 The endothelial cells produce and release a variety of vasoactive substances, including nitric oxide (NO). 10 NO is a powerful vasodilator which is derived from L-arginine by the action of NO synthase. 11 Many reports have demonstrated that endothelial dysfunction of NO synthesis and release is present, or even precedes cardiovascular changes associated with hypertension and aging. [12][13][14][15][16][17][18][19] Thus, endothelial dysfunction may participate the development of hypertension and age-related changes in the coronary vasculature and myocardium. Therefore, the purpose of this study was to examine whether prolonged L-arginine administration, the initiator of NO production, could modulate cardiac fibrosis and deterioration of coronary hemodynamics in both old and hypertensive rats. To differentiate between hypertension-and age-induced changes, the results obtained in aging normotensive WistarKyoto rats (WKYs)...